SCHOLAR ROCK HOLDING CORP
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About SRRK
Scholar Rock Holding Corporation is a late-stage biopharmaceutical company. It is focused on advancing treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases. Its transforming growth factor beta (TGFb) superfamily biology, its novel molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target the precursor, or latent, forms of growth factors. Its product candidate, apitegromab, is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Apitegromab is being developed as a potential first muscle-targeted therapy for the treatment of SMA. Its products include SRK-439, SRK-181, SRK-373 and SRK-256. SRK-181 is a selective inhibitor of the activation of latent TGFb1, is being developed for the treatment of cancers.
Find out what a historical investment in SCHOLAR ROCK HOLDING CORP would be worth today using our SRRK stock calculator.
$3.23B
-
0.00%
3.22M
$36.90
$33.04
$36.56
$46.98
$6.76
Ready to start your investing journey with Stake?
Open an accountSRRK FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SRRK
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SRRK
on Stake
Buy SRRK from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of SRRK from only US$10 with fractional shares
